全文获取类型
收费全文 | 37016篇 |
免费 | 2674篇 |
国内免费 | 159篇 |
专业分类
耳鼻咽喉 | 282篇 |
儿科学 | 1078篇 |
妇产科学 | 731篇 |
基础医学 | 4599篇 |
口腔科学 | 643篇 |
临床医学 | 3572篇 |
内科学 | 8327篇 |
皮肤病学 | 563篇 |
神经病学 | 3981篇 |
特种医学 | 1155篇 |
外国民族医学 | 1篇 |
外科学 | 5214篇 |
综合类 | 526篇 |
一般理论 | 30篇 |
预防医学 | 3046篇 |
眼科学 | 741篇 |
药学 | 2619篇 |
1篇 | |
中国医学 | 54篇 |
肿瘤学 | 2686篇 |
出版年
2023年 | 234篇 |
2022年 | 349篇 |
2021年 | 711篇 |
2020年 | 480篇 |
2019年 | 702篇 |
2018年 | 808篇 |
2017年 | 620篇 |
2016年 | 675篇 |
2015年 | 818篇 |
2014年 | 1159篇 |
2013年 | 1625篇 |
2012年 | 2420篇 |
2011年 | 2711篇 |
2010年 | 1505篇 |
2009年 | 1387篇 |
2008年 | 2298篇 |
2007年 | 2597篇 |
2006年 | 2464篇 |
2005年 | 2550篇 |
2004年 | 2303篇 |
2003年 | 2182篇 |
2002年 | 2018篇 |
2001年 | 341篇 |
2000年 | 266篇 |
1999年 | 401篇 |
1998年 | 451篇 |
1997年 | 338篇 |
1996年 | 335篇 |
1995年 | 276篇 |
1994年 | 245篇 |
1993年 | 277篇 |
1992年 | 238篇 |
1991年 | 225篇 |
1990年 | 183篇 |
1989年 | 160篇 |
1988年 | 170篇 |
1987年 | 151篇 |
1986年 | 117篇 |
1985年 | 177篇 |
1984年 | 246篇 |
1983年 | 205篇 |
1982年 | 242篇 |
1981年 | 248篇 |
1980年 | 240篇 |
1979年 | 116篇 |
1978年 | 131篇 |
1977年 | 127篇 |
1976年 | 114篇 |
1974年 | 92篇 |
1973年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Veena Kumari Jeffrey A. Gray Philip J. Corr Owen F. Mulligan Paul A. Cotter Stuart A. Checkley 《Psychopharmacology》1997,129(3):271-276
The effects of an indirect dopamine-agonist, d-amphetamine, and a non-selective dopamine receptor antagonist, haloperidol, were investigated in normal male volunteers using
a between-subjects double-blind design in a procedural learning task, thought mainly to involve unconscious/automatic learning.
The results showed: (1) d-amphetamine facilitated response speed, whereas haloperidol inhibited it, in comparison to placebo; (2) the linear increase
in procedural learning corresponded with pharmacological manipulation of degree of dopaminergic activity, i.e. subjects given
haloperidol showed the least, and subjects given d-amphetamine the greatest, procedural learning. The implications of these findings are discussed in relation to investigation
of abnormalities of procedural learning processes in schizophrenia.
Received: 28 June 1996/Final version: 2 October 1996 相似文献
22.
23.
24.
25.
26.
Characterization of gp 50, a major glycoprotein present in rat brain synaptic membranes, with a monoclonal antibody 总被引:4,自引:0,他引:4
Philip W. Beesley Toni Paladino Claude Gravel Richard A. Hawkes James W. Gurd 《Brain research》1987,408(1-2):65-78
Several cell lines secreting monoclonal antibodies (Mabs) against a major forebrain synaptic membrane (SM) glycoprotein, gp 50, have been raised. Western blots show that the Mabs react with a polypeptide doublet of Mrs 49 and 45 kDa. These polypeptides exist solely in a concanavalin A (Con A) binding form. Removal of the Con A receptors by digestion with endo-beta-N-acetylglucosaminidase H (endo H) lowers the Mrs of the glycoprotein doublet to 36.5 and 34 kDa. Western blots of 2D polyacrylamide gels indicate that gp 50 exists in several isoforms. Solid phase radioimmunoassay (RIA) and Western blots of brain subcellular fractions show the antigenic material to be concentrated in the SM fraction, but to be present in much lower amounts in synaptic junctions and postsynaptic densities. Gp 50 appears to be brain specific. Regional distribution studies show that it is present in all brain regions but is two-fold concentrated in cerebellum, brainstem and midbrain compared to forebrain. Immunocytochemical studies of several brain regions show that gp 50-like immunoreactivity is neuron specific and is concentrated in selected neuronal species, particularly granule cells. In both cerebellar and hippocampal granule cells gp 50-like immunoreactivity is localized in the perikarya and primary dendrites. Though immunocytochemistry did not show staining of synaptic regions this may be due to masking of the reactive epitope. The results are discussed in terms of the molecular properties of gp 50 and its subcellular localization in brain tissue. 相似文献
27.
Prof. Philip Harber Kaochoy Saechao Catherine Boomus 《Adverse drug reactions and toxicological reviews》2006,25(4):261-272
Diacetyl is a diketone flavouring agent that is commonly employed for buttery taste as well as other purposes. Industrial exposure to flavouring agents, particularly diacetyl, has recently been associated with bronchiolitis obliterans, a severe respiratory illness producing fibrosis and obstruction of the small airways. This has been most commonly reported in the microwave popcorn production industry, but it has occurred elsewhere. In addition to bronchiolitis obliterans, spirometry abnormalities (fixed airflow obstruction) and respiratory symptoms have been associated with exposure. A direct effect on the respiratory epithelium with the disorganised fibrotic repair appears most likely as the underlying mechanism. Current data suggest that diacetyl is the agent responsible, although it is possible that diacetyl is simply a marker for another causative agent. 相似文献
28.
29.
Philip Steer 《BJOG : an international journal of obstetrics and gynaecology》2005,112(S1):109-112
Until recently, bioethics (ethics related to biology or, more specifically, in the context of preterm labour, medical ethics) was considered mainly to relate to the active treatment or investigation of patients. Collection of data, excised specimens or even whole organs was considered to be relatively uncontentious as it did not impinge directly upon the health of the individual concerned. However, in the UK in particular, the practice of collecting data, tissues or even whole organs has recently come under the spotlight of public scrutiny, particularly following the Alder Hey Enquiry. Coincidentally with a decline in public confidence in the probity of authority, medical scientists increasingly have to justify the accumulation of data about individuals. 相似文献
30.
Bill J Gurley Ashley Swain Gary W Barone D Keith Williams Philip Breen C Ryan Yates Leslie B Stuart Martha A Hubbard Yudong Tong Sreekhar Cheboyina 《Drug metabolism and disposition》2007,35(2):240-245
Phytochemical-mediated modulation of P-glycoprotein (P-gp) and other drug transporters may give rise to many herb-drug interactions. Serial plasma concentration-time profiles of the P-gp substrate, digoxin, were used to determine whether supplementation with goldenseal or kava kava modified P-gp activity in vivo. Twenty healthy volunteers were randomly assigned to receive a standardized goldenseal (3210 mg daily) or kava kava (1227 mg daily) supplement for 14 days, followed by a 30-day washout period. Subjects were also randomized to receive rifampin (600 mg daily, 7 days) and clarithromycin (1000 mg daily, 7 days) as positive controls for P-gp induction and inhibition, respectively. Digoxin (Lanoxin, 0.5 mg) was administered p.o. before and at the end of each supplementation and control period. Serial digoxin plasma concentrations were obtained over 24 h and analyzed by chemiluminescent immunoassay. Comparisons of area under the curve (AUC)((0-3)), AUC((0-24)), C(max,) CL/F, and elimination half-life were used to assess the effects of goldenseal, kava kava, rifampin, and clarithromycin on digoxin pharmacokinetics. Rifampin produced significant reductions (p < 0.01) in AUC((0-3)), AUC((0-24)), CL/F, t(1/2), and C(max), whereas clarithromycin increased these parameters significantly (p < 0.01). With the exception of goldenseal's effect on C(max) (14% increase), no statistically significant effects on digoxin pharmacokinetics were observed following supplementation with either goldenseal or kava kava. When compared with rifampin and clarithromycin, supplementation with these specific formulations of goldenseal or kava kava did not appear to affect digoxin pharmacokinetics, suggesting that these supplements are not potent modulators of P-gp in vivo. 相似文献